{"id":13585,"date":"2011-02-03T07:30:00","date_gmt":"2011-02-03T06:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/sanofi-aventis-lancia-la-linea-oenobiol-per-la-bellezza\/"},"modified":"2011-02-03T07:30:00","modified_gmt":"2011-02-03T06:30:00","slug":"sanofi-aventis-lancia-la-linea-oenobiol-per-la-bellezza","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/sanofi-aventis-lancia-la-linea-oenobiol-per-la-bellezza\/","title":{"rendered":"Sanofi Aventis launches the Oenobiol line for beauty"},"content":{"rendered":"

(AGI) - Milan, 2 Feb. \u2013 Sanofi-Aventis will also market the product line of Oenobiol Laboratories in Italy, following the acquisition of the transalpine brand, the French leader in food supplements for beauty, which took place in 2010. Oenobiol Laboratories achieved a turnover of 57.2 million euros, 85 percent tied to the French market and the remaining 15 to foreign markets, in particular Italy, Spain, Belgium, Poland and Portugal. In Italy Sanofi-aventis recorded total revenues of 1,517.3 million euros in 2009, total sales of 1,213.6 million and a market share of 6.6 percent. "The acquisition of Oenobiol represents for Sanofi-aventis a further example of attention to the needs of patients", explained Arturo Zanni, general manager of Sanofi-aventis Italy, "and complements the already consolidated and wide range of products intended for health. Sanofi-aventis is currently able to offer patients drugs prescribed on prescription by general practitioners and specialists, both in hospitals and outpatient clinics, vaccines, equivalent medicines of the highest quality and a range of self-medication products cation". With the Oenobiol brand, added Zanni, "we further expand our presence in the pharmacy channel by embracing the so-called 'nutraceuticals' category and, in particular, a line of products capable of promoting all-round female beauty and well-being".<\/font> (AGI) . \"\"<\/p>\n

\"L'histoire\"      \"\"
Daughter and granddaughter of doctors, herself a nutritionist, Dr. Marie B\u00e9jot (photo<\/em>) inherited from his father, a botanist, his passion for nature, spending his childhood in Africa.<\/p>\n

<\/font><\/font><\/p>\n

After studying in Dakar and Paris, Marie B\u00e9jot has specialized since 1978 in aesthetic medicine and opened her own studio dedicating herself to treatments to combat overweight and aging. It was in this period that he developed the concept of beauty through nutrition and developed the first beauty supplements that respond to the specific needs of patients. <\/p>\n

<\/font><\/font><\/p>\n

With the help of her husband, she sets up a small company to market her beauty supplements. In 1985 the Oenobiol brand was born and its first product, a moisturizing capsule with omega 3 fatty acids. <\/p>\n

<\/font><\/font><\/p>\n

In 1989, Marie introduced an innovative concept: a sun capsule that does not color the skin, but protects it and promotes tanning by activating melanin synthesis. Oenobiol Solaire, the subject of a published clinical study, is today the No. 1 in France in the sector of food supplements for tanning and certainly the flagship product of Oenobiol.<\/p>\n

<\/font><\/font><\/p>\n

With the launch of Oenobiol Solaire, the company takes off. Dr. Marie B\u00e9jot can finally men<\/p>","protected":false},"excerpt":{"rendered":"

(AGI) – Milano, 2 feb. – Sanofi-Aventis commercializzera’ anche in Italia la linea di prodotti dei Laboratori Oenobiol, in seguito all’acquisizione del marchio d’Oltralpe leader francese negli integratori alimentari per la bellezza, avvenuta nel 2010. I Laboratori Oenobiol hanno realizzato un fatturato di 57,2 milioni di euro, legato per l’85 per cento al mercato francese …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13585","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13585"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13585\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}